Hill's Pet Nutrition has highlighted recent studies which, the company says, prove that feeding a food enriched with omega-3 fatty acids from fish oils to dogs with osteoarthritis results in a reduction in NSAID dosage of up to 25%1, owner observed improvements in clinical signs3, and improved weight bearing ability2, 7
The claim that food can effectively support medical treatment follows in the wake of two published and one in press study in the Journal of the American Veterinary Medicine Association (JAVMA). These demonstrate that omega-3 enriched food (in this case Hill's Prescription Diet j/d Canine) has significant effects on weight bearing and helps reduce NSAID dosage by up to 25 per cent, when fed to dogs with osteoarthritis 1, 2,3.
According to Hill's, the research demonstrates that in dogs the high levels of eicosapentaenoic acid (EPA) from fish oils can down-regulate the cartilage degrading enzyme aggrecanase1. In vitro studies have also identified that EPA resulted in a reduction in the amount of degraded cartilage residue produced4. High levels of omega-3 fatty acids can also help to reduce inflammation5,6.
The two studies that were recently published confirm that feeding a diet rich in omega-3 fatty acids aids in the management of osteoarthritis in dogs2,3. The randomized double-blinded controlled trials were carried out over three and six months respectively and involved a total of 165 dogs identified as suffering from mild to moderate osteoarthritis. After collating the results from almost 25,000 trial days, researchers were able to confirm a significant 'clinical improvement' from feeding a food fortified with fatty acids.
In the first study described in JAVMA, researchers found evidence that omega-3 fatty acids from fish oils resulted in improvements in weight bearing2. Objective measurement using force plate gait analysis demonstrated that dogs fed a test food fortified with fatty acids were seven times as likely to show improved weight bearing compared with dogs fed a control food.
In the second study, through a detailed questionnaire, owners also observed significant improvements in their dog's osteoarthritic condition3. Improvements observed covered the following signs: difficulty in rising from rest, limping, stiffness, soreness when touched, yelping or whimpering in pain, aggression, lagging on walks, reluctance to play and overall activity level.
Adrian Pratt, Veterinary Affairs Manager for Hill's Pet Nutrition, manufacturer of Prescription Diet j/d, which is enriched with omega-3 fatty acids, hailed the results as a breakthrough in the field of nutrigenomics (the study of the effects of nutrition on gene expression): "This research points the way to a new model for the management of osteoarthritis, using a clinically proven food to interrupt the cycle of damage and cartilage degradation, alongside graded levels of NSAIDs and proactive programmes to manage weight and adjust exercise routines. Clinicians now have the conclusive proof they need to recommend feeding omega-3 enriched food to ameliorate the signs of osteoarthritis in clients' pets and to adjust NSAID doses accordingly."
For further information on Hill's Prescription Diet j/d, please contact your Hill's Territory Manager or call 0800 282438.
References1. A multicenter study of the effect of a therapeutic food supplemented with fish oil omega-3 fatty acids on the Carpofen dosage in dogs with osteoarthritis. Fritsch A, Allen T, Dodd C, JAVMA in press2. Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs. Roush J, Cross A, Renberg W, Dodd C, Sixby K, Fritsch A, Allen T, Jewell, Richardson D, Leventhal P, Hahn K, JAVMA Vol 236 No 1, Jan 2010 pp67-733. Multicenter veterinary practice assessment of the effects of omega-3 fatty acids on osteoarthritis in dogs. Roush J, Dodd C, Fritsch A, Allen T, Jewell D, Schoenherr W, Richardson D, Leventhal P, Hahn K, JAVMA Vol 236 No 1, Jan 2010 pp 59-664. Eicosapentaenoate supplementation abrogates canine articular cartilage degeneration in in vitro explant culture systems, Caterson B, Cramp J, Little C B et al, Hills European Symposium on osteoarthritis and joint health 2005 14-195. Dietary modification of inflammation with lipids, P C Calder, Proceedings of the Nutrition Society 2002 345-3586. Dietary polyunsaturated fatty acids and inflammatory mediator production, James M J, Cleland L G, Gibson R A, Am J Clin Nut 2000: 71 suppl 343S- 358S7. Vasseur PB, Johnson AL, Budsberg SC, et al. Randomized, controlled trial of the efficacy of carprofen, a nonsteroidal anti-inflammatory drug, in the treatment of osteoarthritis in dogs. J Am Vet Med Assoc 1995; 206 (6): 807-811.
Acepromazine-based Acecare is used alongside other opioids and reduces the amount of anaesthetic necessary to induce anaesthesia by approximately one third.
Animalcare Product Manager Eleanor Workman Wright said: "Practices are looking for greater cost-effectiveness in the products they use and are also keen to reduce waste.
"We are delighted to announce that Acecare, a trusted staple of anaesthetic protocols in use at many practices is now offering improved performance in both of these areas.”
For more information, contact your Animalcare Territory Manager or contact Animalcare’s head office on 01904 487687.
Presented by Sam Taylor BVetMed(Hons) CertSAM DipECVIM-CA MANZCVS FRCVS, the webinar will also be available to watch on demand later, for those who miss it.
Sam is an Internal Medicine and Feline Specialist and current ISFM Academy lead.
She recently chaired and co-authored the ISFM guidelines on the management of the inappetent hospitalised cat.
The webinar, which counts for one hour’s CPD, will cover:
Sarah Musgrave, Brand Manager at Dechra, said: “Inappetence is a common reason cats present to veterinary practices and it can be caused by multiple conditions.
"Management needs to look beyond just treating the underlying disease as factors such as stress, nausea and pain can play a significant role.
"Untreated inappetence has a substantial negative effect on recovery from illness and surgery, makes medicating cats difficult and may even hasten euthanasia decisions.
"The ‘Feline pawsative about feline inappetence?’ webinar will help educate on feline weight loss, why intervention to improve nutrition is important and the practical steps to treating inappetence.”
https://thewebinarvet.com/webinars/feline-pawsative-about-feline-inappetence.
The RSPB has reported the results of two studies which revealed that a greater diversity of birds of prey, including some eagles, are killed eating carrion contaminated with diclofenac.
The RSPB says that these findings strengthen the case of banning the use of veterinary diclofenac in livestock across Europe, including Spain and Italy where the drug has already been approved.
In the first paper1, published in the journal Bird Conservation International, scientists present results of tests carried out on two steppe eagles found dead at a cattle carcass dump in Rajasthan, India. Both birds had diclofenac residue in their tissues and exhibited the same clinical signs of kidney failure as seen in Gyps vultures experimentally given diclofenac.
Steppe eagles are closely related to the golden eagles found in the UK, the vulnerable Spanish imperial eagle and other globally vulnerable or declining Eurasian eagles. Scientists now fear that all species in this genus, known as Aquila, are susceptible to diclofenac. With fourteen species of Aquila eagle distributed across Asia, Africa, Australia, Europe and North America, this means that diclofenac poisoning should now be considered largely a global problem.
Dr Toby Galligan, RSPB conservation scientist and one of the authors of the paper, said: "We have known for some time that diclofenac is toxic to Gyps vultures, including the Eurasian griffon vulture, but we now know it is toxic to an Aquila eagle too. This suggests that the drug is fatal to a greater number of birds of prey in Asia, Europe and around the world. We had suspected as much from observed declines in non-Gyps vultures in Asia, but this study confirms our worst fears."
In another paper2, published in Bird Conservation International, Dr Galligan led an examination of recent population trends in Egyptian and red-headed vultures in India. That study shows population declines of similar timing and scale as the declines observed in Gyps vultures, providing indirect evidence that these species have been impacted by diclofenac as well.
After years of campaigning by conservationists, the governments of Bangladesh, India, Nepal, and Pakistan banned veterinary formulations of diclofenac between 2006 and 2010. Recently, experts have recorded a slowing of Gyps vulture declines as a result of the bans. However, formulations of diclofenac intended for use in humans are still widely available and illegally used to treat livestock, the carcasses of which are the main food source for vultures in South Asia. It was announced in March that veterinary diclofenac had been authorised for manufacture and use in Italy and Spain and had been distributed to other European countries. Since then, a coalition of organisations including the Vulture Conservation Foundation, the RSPB and BirdLife International have been campaigning for this decision to be reversed.
Dr Galligan continued: "In light of recent developments in Europe, our findings take on an even more worrying meaning. All of Europe's charismatic Aquila eagles, like the Spanish imperial eagle and, closer to home, the golden eagle, are opportunistic scavengers and therefore could be at risk of diclofenac poisoning. As we have seen in South Asia, wherever free-ranging livestock are treated with diclofenac, population declines in vultures and eagles can occur. The European Commission needs to recognise this problem and impose a continent-wide ban on veterinary diclofenac before it can impact on our birds."
Last week, the Veterinary Medicines Directorate (VMD) announced measures against the drug.
In a statement the VMD said: "The UK's Veterinary Medicines Directorate is taking the issue of diclofenac's risks to vulture populations seriously. As a precautionary measure the VMD will not approve any requests from vets to import products containing diclofenac. Furthermore, the VMD has agreed not to issue any export certificates which name diclofenac-containing products in the list of products to be exported."
Sacha Cleminson, Head of International Biodiversity Policy at the RSPB, said: "The announcement from the Veterinary Medicines Directorate is a welcome signal to Europe that the UK is taking the issue seriously. This new evidence underlines the need for a ban across Europe, and ultimately beyond."
References
Have population declines in Egyptian Vulture and Red-headed Vulture in India slowed since the 2006 ban on veterinary diclofenac? Toby H. Galligan et al. Bird Conservation International Online. 1st April 2014.
Pfizer Animal Health's Equine Herpes Virus (EHV) vaccine (Duvaxyn EHV 1,4) has been rebranded Equip EHV 1,4).
Pfizer says that EHV is carried by most horses in the UK1 and can cause respiratory disease, abortion and more rarely neurological disease. However, it is the more common sub-clinical infections that pose the most apparent issue for the competition client, with the associated loss of performance and the potential effect on the health of the whole yard.
Once infected with EHV, a horse can harbour the virus throughout its life and potentially shed the disease to other animals without showing any outward signs. According to the company, vaccinating helps to minimise the severity of the disease itself and importantly, can also help to reduce the amount of infective virus that is shed to other in-contact horses.
Equip EHV 1,4 is given as a primary course of two vaccinations, 4-6 weeks apart followed by a single dose every six months. It can also be used as an aid in the control of EHV-1 abortion - pregnant mares should be vaccinated with a single dose during each of the 5th, 7th and 9th months of pregnancy.
For further information on Pfizer's EHV campaign, to obtain literature for your practice or to book a talk for your clients contact your Pfizer Account Manager or Pfizer Animal Health, Walton Oaks, Tadworth, Surrey KT20 7NS.
Reference
1. Eddington et al. Equine Vet. J. 1994; 26 (2): 140-142.
The clinic offers Specialist care primarily for patients with osteoarthritis pain, but also those with chronic pain caused by other conditions, such as cancer, dental and ear diseases, spinal disease and feline hyperaesthesia syndrome.
BVS says cats and dogs coming to the clinic will get the highest level of care with a specialist assessment from Jo, who also also works closely with the orthopaedic and neurology services to offer a global and holistic approach.
The assessment will identify signs of chronic pain, gauge the severity, and also evaluate the impact of the condition on the animal’s quality of life.
Jo says it is important to identify these conditions as early as possible, as instigating pain management early helps to dampen down pain signals and reduce overall upregulation of the pain pathways.
To that end, Jo uses validated clinical metrology instruments (owner questionnaires) to measure the severity of pain, especially during initial appointments.
Should a condition be detected, Jo and her team will be able to offer pharmacotherapy, intra-articular and epidural injections and acupuncture.
Jo also works closely with physiotherapists and hydrotherapy services, which can be used as adjunctive therapy.
Jo said, said: “Many cats and dogs will experience chronic pain. These cases need to be thoroughly investigated to ensure that the cause of pain is properly identified and treatment quickly provided. We are very pleased to be able to open our new chronic pain clinic for cat and dog owners in the South West today to provide this essential service.”
https://www.bristolvetspecialists.co.uk
Invicta Animal Health has launched SynVet-50, a licensed synthetic Sodium Hyaluronate (HA), for intra-articular treatment of lameness caused by joint dysfunction associated with non-infectious synovitis in horses.
The product is Invicta's first licensed medicine.
According to the company, the functional mechanisms of HA are directly dependent on the molecular weight and concentration of HA. 1 Therefore, SynVet-50 has been formulated with a molecular weight of 1.5m Daltons which is the highest of any synthetic HA available in the UK.
Invicta says that at 20mg per ml, SynVet-50 is also the most concentrated HA available.
Storage is at ambient temperature.
SynVet-50 is a 2.5ml solution containing 50mg HA, conveniently presented in a 5ml glass syringe.
Rob Watkins, Managing Director of Invicta said: "We are excited to be launching our first licensed medicine in the UK. The management team of Invicta have over 10 years experience in this market which has allowed us to provide a product strongly focussed on the clinicians needs, not just in terms of technical ability, but also in convenience of presentation".
For further information see www.invictavet.com or phone 01403 791313
The courses are:
MMI Manager Lisa Quigley commented: “I am really proud of this new tranche of training.
"Whereas our previous training has focused on the individual experience, for example, mental health awareness and resilience, these new courses recognise that individual instances of poor mental health and wellbeing can often be caused by systemic issues – whether that’s a poor workplace culture where bullying and incivility thrive, or discrimination on account of someone’s protected characteristics.
The full range of courses, including the dates and times and details on how to register, can be found at www.vetmindmatters.org/training
Feedback about any of the courses can be sent to info@vetmindmatters.org
The BetterwithPets Prize invites entries from entrepreneurs whose work focuses on the power of the pet human bond and whose efforts are helping to transform society. Purina runs the prize in collaboration with Ashoka, a pioneer in the field of social entrepreneurship.
StreetVet was shortlisted from 150 applicants from Europe, the Middle East and North Africa. Its Accredited Hostel Scheme offers free, accessible veterinary care for pets whose owners are experiencing homelessness and support for hostel managers and staff to adopt and implement positive pet policies.
Jade Statt, co-founder of StreetVet said: “Discovering a competition that celebrates the importance of the human animal bond felt like fate, one the StreetVet team felt compelled to enter. We are so delighted that we did! Going through this process has been really enlightening and we are beyond pleased that our project has reached the final, it is a real privilege."
The finalists will take part in an online pitch on 3rd June 2020, following which, Bernard Meunier, CEO, Nestlé Purina PetCare EMENA will announce the winners.
Mary Sharrock, External Relations Director, Purina, said: "The work StreetVet do is simply amazing and I’m delighted they’ve made the shortlist. Throughout the selection process for the BetterwithPets Prize, we found ourselves inspired by so many of the initiatives which harnessed the pet-human bond in such innovative ways and create positive changes in communities."
The workshop will be hosted by Renzo Di Florio (pictured right), veterinary advisor at Ceva Animal Health.
The session will look at the impact of Q Fever in the UK, outlining how it affects cattle health and reproductive performance and productivity.
It'll also cover identification of the disease and diagnosis, and prevention through vaccination and treatment.
For further information and to book tickets for TotalDairy, visit www.totaldairy.com (Ceva can offer a 10% discount on the purchase of tickets to the event using the code CEVA10).
The study, which was carried out by researchers from the School of Veterinary Medicine and Sciences at the University of Nottingham, is one of the first to look at colostrum hygiene in Great Britain. The researchers analysed data from 328 colostrum samples from 56 British dairy farms.
Samples collected from collection and feeding equipment had higher levels of bacteria than those collected directly from the cows’ teat, suggesting that whilst colostrum from the cow is relatively low in bacterial levels, improperly cleaned equipment can be a major source of bacterial contamination. Over one third of samples collected from collection or feeding equipment were over the threshold for high bacterial levels and represented a significant risk to the health of calves.
Dr Robert Hyde (pictured right), one of the researchers on the study, said: “By analysing colostrum collection protocols on the farms, we were able to identify a small number of management practices likely to have a substantial impact on colostrum hygiene for the majority of farms.
"For example, the use of scalding hot water to clean collection and feeding equipment could reduce bacteria levels by over 90% compared with using cold water only. Less than half of farms used scalding hot water to clean colostrum collection and feeding equipment, suggesting there are a large number of farms that could make this simple change.”
The main recommendations from the research are that colostrum hygiene protocols should include the cleaning of colostrum collection and feeding equipment after every use with hot water as opposed to cold water, and hypochlorite or peracetic acid as opposed to water or parlour wash.
Cows' teats should be prepared with a pre-milking teat disinfectant and wiped with a clean, dry paper towel prior to colostrum collection, and colostrum should be pasteurised where possible.
The AHDB guide to colostrum hygiene can be found here: https://www.youtube.com/watch?v=FziQX0B9yb4
Robert added: “This study provides a first look at bacteria levels in Great Britain, and the results suggest there are a few simple changes to collection and cleaning protocols that could have a significant impact on colostrum hygiene levels on British dairy farms. By making these simple changes there is likely to be significant improvement in colostrum hygiene, which is essential in minimising the risk of disease and ensuring the optimum health and welfare of calves on dairy farms.”
The full study is open access and can be found here: https://www.frontiersin.org/articles/10.3389/fvets.2020.601227/full
The University of Nottingham herd health toolkit contains a “Colostrum bacteriology” section, where vets and farmers can use the results from this study to see what management changes might have the largest impact on colostrum hygiene, can be found here: https://herdhealth.shinyapps.io/toolkit/
CFH Docmail, a traditional print and posting service that you manage entirely online, has introduced personalised colour postcards to its range.
Docmail mailings - whether a single letter or a personalised mailing to thousands - are written and created on-line by the originator, sent electronically to Docmail where they are printed and delivered via CFH's own Downstream Access (DSA) facility.
Whether for appointment reminders or other practice messages, the remarkable thing about this service seems to be the price: from 27p plus VAT for A6 colour postcards printed on both sides, including production and postage. The postcards can either be designed via a template on the Docmail website, or you can upload your own artwork. There's no minimum order, and Docmail mails the personalised cards out on a two day standard delivery to the address database that you provide.
Dave Broadway, managing director of CFH Total Document Management, creators of Docmail said: "Postcards are of course an established means of communication. What's different about Docmail is that production and mailing costs are considerably cheaper than traditional methods.
"Our user friendly website is quick and easy to navigate, and you have total control over the contents of your mailing."
Fraser Robertson, Financial Director of Docmail customer Eye Tech Group said: "We've been using Docmail for our regular mailings for some time now, and the introduction of postcards will be invaluable for our appointment reminders. We estimate that Docmail is saving us over 60p per letter and crucially is also freeing up administrative time."
For more information, visit: http://www.cfhdocmail.com/vets/index.html
The British Veterinary Association has responded to the announcement of a recruitment drive by the newly-formed British Veterinary Union (BVU) and Unite.
Harvey Locke, President of the BVA, said: "Those working in veterinary practice have always been able to join Unite or any other trade union, and it is unclear whether vets are actually being offered anything new in this recruitment campaign.
"The BVA provides the majority of services traditionally offered by a union and we are constantly working to improve our services to support the veterinary team. In the last two years we have developed mediation and legal representation services to help members through difficult issues in the workplace. The BVA's 24/7 legal helpline remains one of our most valued services with up to 600 calls year on employment and personal issues. We also produce and update a wide range of advice and guidance on all aspects of veterinary employment.
"All of our services continue to be developed using the expertise and experiences of our members.
"In addition to these support services the BVA package incorporates much more. The BVA is a key stakeholder of the RCVS, Defra, Welsh, Scottish and Northern Ireland administrations, the VMD and other bodies, representing members on issues as diverse as pet travel, bovine TB and medicines regulations. This is not a role Unite could play for our profession."
60 vets took part in the survey. 80% believed they had seen an increase in behavioural problems since lockdown. Over 60% reported an increase in the incidence of obesity and diarrhoea. Nearly 50% had seen an increase in urinary tract disorders and haemorrhagic gastroenteritis.
When asked which conditions had been harder to manage clinically since the start of the pandemic, the top seven conditions were:
Medicine specialist, Dr Stefanie Mitze (pictured right) said: “We conducted the survey to help us understand changes in disease incidence and the clinical challenges faced by our colleagues in first opinion practice over the last year.
"The fact that the incidence of disorders which can have a stress-related component, including behavioural problems, diarrhoea and urinary tract disease, were reported to have increased by a high proportion of respondents indicates that many pets may be experiencing heightened stress during the pandemic.”
Stefanie is now creating a series of free bitesize CPD videos to help manage these more challenging cases. She said: “We recognise the past year has been challenging, especially with complex staffing issues, reduced vet visits and restricted face-to-face communication with clients. For complex, chronic medical conditions, especially those which require frequent follow up, we wanted to support colleagues in providing the best care possible in the current circumstances. We hope these CPD sessions will provide practical tips to help deliver just that.
The CPD sessions are available at: https://www.hamiltonspecialists.vet
Millpledge has launched Dermafuse Tissue Adhesive, an n-butyl cyanoacrylate medical adhesive used to bond tissue together following veterinary procedures.
Dermafuse contains a blue dye to help users see where product has been applied.
On contact with body tissue, Dermafuse changes from liquid to solid state by polymerizing within seconds to seal the wound.
Millpledge says the adhesive stops minor bleeding and binds wound edges, which may eliminate the need for sutures or bandages. In some instances it also acts as a barrier to keep foreign matter from entering the wound. The tissue adhesive is sloughed as healing occurs.
Each 3g bottle contains approximately 175 drops. Four sterile applicator tips are provided with each pack.
The Dairy Vet of the Year award, which is organised by the British Dairying Magazine and sponsored by Krka UK Ltd, recognises a veterinary surgeon for going the extra mile in helping to create a more positive, forward-thinking dairy industry.
In addition to her work as a farm vet, Sarah is also Technical Director at the TB Advisory Service (TBAS), which involves her overseeing and delivering training for new advisors, chairing technical board meetings and delivering farmer meetings across the country. She also provides bespoke advice to farmers in High Risk and Edge Areas of England, and is known for her compassion and understanding for those suffering a TB breakdown.
She is also a member of the TB Eradication and Advisory Group (TBEAG) for England, which advises government policy makers on all aspects of TB control in England.
Lindsay Heasman, Project Manager at TBAS, said: “Sarah is an authority on TB and understands the responsibility that comes with this role. She uses her position for good at all times and is prepared to make statements that are not always universally popular. By standing by her beliefs and dispelling misconceptions, she has won the respect of farmers across the country. Her dedication has, at times, come at personal cost, but her passion for eradicating bTB and support for farmers in achieving this goal never wavers.”
Sarah said: “I am just a farm vet doing the same job every farm vet does daily across the country. Through necessity, seeing my clients being devastated by TB breakdowns every day, I felt passionate about doing something about it. TBAS, my colleagues I am lucky to work with, and TBEAG have given me the platform to do this. I am very humbled that the judges though me worthy of the Award amongst the other hard-working vets."
Photo: Giles Brandreth, Charlotte Read, Sarah Tomlinson and Sean Sparling
The UK dog-owning public is being duped into buying dogs from puppy farms says Dogs Trust, the UK's largest dog welfare charity, inadvertently fuelling the cruel trade and potentially landing themselves with huge vet bills.
In a recent survey the charity asked dog owners if they would consider buying a dog from a puppy farm. Although almost 95% said no, when asked where they had got their dog from 15.1% - potentially 900,000 dog owners - admitted they had got them from an advert in the newspaper, the internet, a pet shop or a pet superstore, all outlets often supplied by puppy farms.
In the past six months Dogs Trust has seen a marked increase in calls from concerned members of the public on the subject of puppy farming, many from dog owners whose pets have suffered illness and in some cases died as a result of having been bred at puppy farms.
Dogs Trust is calling for immediate measures to help to stop the puppy farming trade:
1. General publicDogs Trust is introducing the term 'battery farming of dogs' to associate the practice in the minds of the public with that of battery farming of chickens, and wants to educate the public as to where they can safely go to buy a 'cruelty free dog'.
Dogs Trust's message to the public is:
2. Government & Local AuthoritiesDogs Trust is calling for the review of existing breeding licensing legislation.
Clarissa Baldwin, CEO of Dogs Trust, said: "Battery farming of dogs is an appalling practice, abhorrent to all decent members of society. Breeding bitches are kept in unthinkably cruel conditions and bred from continuously until they are too old, then discarded. Puppies often suffer from medical problems and behavioural issues as a result of being inadequately socialised. While most people would never consider buying a dog from such a place, it seems that a large number are inadvertently doing so.
"Most reputable breeders would never sell their dogs through newspaper adverts, pet shops or superstores, garden centres or internet websites. Anyone who sees an animal for sale in any of these places should be suspicious. Newspaper adverts and online websites are of particular concern since unscrupulous breeders or middle men (dealers) are difficult to identify, often posing as members of the public selling 'puppies from unplanned litters'."
What's wrong with battery farms?Breeding bitches at battery farms:
A battery farmed puppy could have genetic or other health problems relating to its poor breeding conditions. It could also have behavioural problems as a result of being taken from its mother at too young an age.
Common problems for a puppy farmed dog are:
Dogs Trust has published a guide for anyone looking to buy a puppy. It can be downloaded from http://www.dogstrust.org.uk/az/b/buyingadog/default.aspx
The book contains 40 chapters of articles about clinical techniques, diagnostic pathways and management approaches published in Companion between 2016 and 2020.
Editor of Companion, Samantha Taylor said: “At Companion we strive to produce well-illustrated, practical articles to help vets and VNs in practice face the day-to-day challenges of a varied caseload. We hope this collection meets our aims by covering a variety of clinical problems from hypercalcaemia in cats to managing the snuffly rabbit, from Leishmaniasis to lymphoma and many more.
Ian Ramsey (BSAVA Senior Vice President) said: “This collection represents a unique body of well-illustrated work prepared by experts from all around the UK and beyond. I would like to thank them all on behalf of BSAVA members and readers of this book for taking the time and care to develop these resources for their colleagues around the world.”
Samantha added: “Whether kept on the shelf for when needed or thumbed through over a cup of tea, we hope that within the pages of this new volume you find a useful tip or technique that helps.”
The How to…collected articles from BSAVA Companion (2016–2020), 3rd edition has been published as a BSAVA member loyalty reward gift for those eligible veterinary members who renew their membership this year.
The book is also available to buy from the BSAVA website www.bsava.com/shop priced at £20.
Janssen Animal Health has produced a new DVD called 'Fluke: That's a Fact', which is available free from the company.
The 18 minute film features TV presenter Michaela Strachan discussing the big issues surrounding fluke in sheep, such as the effects on productivity and fertility and the need to adapt treatment regimes to reflect the current challenge in the environment, weather patterns and the possibility of resistance to commonly used flukicides. There is also a section on Haemonchus, the Barber's Pole worm, as the parasite has been reported in a number of farms in the last few years.
According to the company, fluke is becoming increasingly common and is moving into new areas of the UK. There is increasing evidence that a single autumn / winter dose of flukicide may not always be enough to control the disease on some farms and more frequent dosing programmes are now often proposed that look more long term to reduce the level of the disease on farms, especially on those farms with high infection pressure. The film clearly explains these different approaches and the benefits of treating at various times of the year.
Janssen's Livestock Marketing Manager Nigel Underwood hopes the film will be a great educational tool that will help both farmers and SQPs better understand the disease: "With ten easy to watch sections, people will be able to listen to the whole story or just dip into those areas where they feel they need to know more. With her long standing interest in the countryside and wildlife, Michaela Strachan was the perfect choice to present what can be a rather complex story and I'm sure everyone will enjoy her clear explanation of the facts."
To request a DVD or for further information, please contact Janssen Animal Health, 50-100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG. Tel 01494 567555 Fax 01494 567556 Email: ahealth@its.jnj.com www.janssenanimalhealth.com/uk
Axiom Laboratories has launched MiPetAllergy, a pet allergy test which the company says is not affected by medication and which requires no withdrawal period prior to testing.
Axiom developed the MiPetAllergy in partnership with ALK, which makes Artuvetrin. With its food elimination diet selector tool, developed in association with Royal Canin, it tests against as many as 80 environmental allergens and foods.
Dan Sherry, General Manager at Axiom, said: "Allergies are increasing among companion animals and identifying accurately which allergen is causing the problem in a particular pet can be one of the toughest challenges veterinary staff face in practice.
"MiPetAllergy represents two and half years of research so we are delighted to announce its arrival. Axiom is confident that there will be complete concordance between the screen and panel results that they are offering a money back guarantee if they are discordant. We hope it will help practices dealing with allergy patients to identify and treat for the specific allergens causing their symptoms."
Martyn Carpenter, Director of Axiom, added: "The introduction of the MiPetAllergy testing is timely as it coincides with the change in Axiom’s supplier of immunotherapy. During November and December 2014 the Veterinary Medicines Directorate (VMD) started rejecting applications for STC’s and advising that European Licensed immunotherapy products should now be used in the UK as part of the Cascade. Both our new allergy test and new vaccines are manufactured by the same company."
Two hundred members of the profession took part. The main results were:
The virtual collection provides a source of evidence to determine what is or is not of clinical significance in cardiac arrhythmia and what might represent the best course of action, if action is needed, within the requisite parameters of safety and welfare.
With an editorial written jointly by Peter Physick-Sheard and Joann Slack the virtual collection includes:
... and more.
Professor Celia Marr, Editor of the EVJ said: “In terms of day-to-day veterinary work, rhythm disturbances are a frequent frustration during prepurchase examinations or perceived poor performance assessments. This outstanding collection brings to hand the most recent evidence to help clinicians support their observations, facilitating diagnosis and a treatment plan in this challenging area.”
The Virtual issue can be downloaded here: https://beva.onlinelibrary.wiley.com/doi/toc/10.1111/(ISSN)2042-3306.irregular-hearts-performance.vi
Elanco says Baycox Iron offers a time-saving flexible dosing treatment which complements the company’s existing piglet gut health portfolio.
Louise Radford, marketing manager at Elanco, said: "By treating piglets at two or three days old, it’s possible to allow enough exposure to the coccidiosis parasite to enable them to develop natural immunity, while preventing any damage to the gut caused by subclinical and clinical coccidiosis which leads to poor growth and low weaning weights.
"By combining treatments, it's possible to limit the number of times they are handled, which in turn reduces stress and enhances growth”.
Elanco also makes the Coliprotec vaccine against post weaning diarrhoea (PWD).
Louise added: “As farmers and vets prepare for the removal of zinc oxide as a treatment option next year, focusing on gut health throughout all stages of development has never been more crucial.
For more information, contact your Elanco pig team specialist or visit https://www.myelanco.co.uk/cpd/swine/hub.
The Soil Association is calling on the Government to issue guidelines that will limit the veterinary use of the most modern penicillin-type antibiotics, to prevent the spread of a serious new superbug.Recently released minutes of a Government committee reveal that Ministers have been briefed about the emergence on a British dairy farm of a mutant strain of antibiotic-resistant E. coli which causes life-threatening cases of food poisoning, including hemorrhagic colitis and haemolytic uraemic syndrome.
The bug, known as E. coli O26 is a vera-toxin producing E. coli (VTEC), similar to the infamous E. coli O157. According to the Soil Association, what makes the discovery of this variant so significant is that this is the first time in the UK, and only the third time in the world, that VTEC E. coli has been found with an enhanced type of antibiotic resistance known as extended-spectrum beta-lactamase (ESBL), which makes it resistant to almost all antibiotics. ESBL resistance has previously been found on 57 UK farms, but until now only in strains of E. coli that cause urinary tract infections and blood poisoning.Although antibiotics are not recommended for the treatment of VTEC E. coli, scientists warn that the emergence of resistance is undesirable because these resistant bacteria are encouraged every time certain antibiotics are used, resulting in increased spread and greater risk of contaminated food products. On non-organic dairy farms, cows are routinely given antibiotics at the end of their lactation to prevent mastitis. In addition, milk from cows given antibiotics for treatment, or prevention, is often fed to calves when it contains residues and cannot be sold. However, because ESBL E. coliO26 is resistant to all the antibiotics used in ‘dry cow therapy' and many of those used for treatment, the high use of antibiotics on dairy farms will promote the rapid spread of these dangerous bacteria.Soil Association Policy Adviser, Richard Young said: "This is one of the most worrying developments in the continuing rise of ESBL E. coli. Today is the first European Antibiotics Awareness Day, but there is a distinct lack of awareness that the continuing high use of antibiotics in farming is contributing to the increase in antibiotic-resistant infections in humans."The Government often calls on doctors to prescribe antibiotics less often. But similar advice needs to be given to veterinary surgeons and farmers. Half of all antibiotics are given to animals, and there is mounting evidence that antibiotic-resistant bacteria in farm animals pass to humans. If we want antibiotics to save lives in the future as they have done in the past then the Government must provide specific recommendations based on scientific advice, and vets need to pull together with doctors to limit the use of problematic drugs."
Norbrook Laboratories Ltd has launched a second generation Eprinomectin Pour On solution with zero milk withhold and a 10 day meat withdrawal period. Eprizero, for beef and dairy cattle, is indicated for the treatment and prevention of a range of economically damaging gutworm and lungworm infections and external parasites in a pour on application. It offers zero milk withhold and an improved meat withdrawal period of 10 days. Andrew Hillan MVB MRCVS, Director of Veterinary Science, Norbrook Laboratories Ltd., said: "Norbrook has launched Eprizero to offer vets and farmers a more versatile alternative in the treatment of economically damaging worms and external parasites. The active ingredient in Eprizero, Eprinomectin, is both potent and fast-acting and is supported by independent studies which show increased milk yield, improved fertility and increased dry matter intake following treatment. With a zero milk and 10 day meat withdrawal and waterproof properties, Eprizero offers real versatility to vets and farmers in terms of when and where they treat. It is this versatility that we believe will make Eprizero the gold standard in anthelmintic treatment for prolonged infestations of gut worm and lung worm in both dairy and beef cattle." Eprizero is available in four sizes - 250ml, 1L, 2.5L and 5L - with a free 75ml gun supplied with the two larger pack sizes. It is administered using a 75ml dispensing gun to enable accurate application. Eprizero is registered for use in the UK and Ireland and is available to order from your local Norbrook Sales Representative.